[M T]

Based on the study results, I wouldn’t want the drug given to me because the side effects likely have a higher chance of hitting me than the drug does having much of a benefit.

I haven't looked at the study, but some of us are at a higher risk of a fatal outcome from COVID-19.  The risk of side effects may be too high for some, but the same risks are acceptable for others.

Now, a more subtle point... If CFR is 20% for an 80+ person in S. Korea that has symptoms & a positive test, what is the IFR for an  80+ person in the US who has a positive test but no symptoms (yet).   That number matters for judging the benefit/risk ratio of a treatment.

I haven't seen any studies that give the age-based incidence of asymptomatic cases.   The whole infection rate is so poorly understood right now.  (As I've said before, the Stanford antibody study may actually show in fact that there is very little community infection, suggesting relatively few asymptomatic cases.  But the maternity studies suggest high infection rates in those locales)

We may actually get numbers for some of the risk groups if areas are doing full (& repeated) testing in retirement homes.  Such numbers don't help with judging herd immunity, but they do help for treatment decisions for those at-risk individuals.

[M T]

Based on the study results, I wouldn’t want the drug given to me because the side effects likely have a higher chance of hitting me than the drug does having much of a benefit.

I haven't looked at the study, but some of us are at a higher risk of a fatal outcome from COVID-19.  The risk of side effects may be too high for some, but the same risks are acceptable for others.

Now, a more subtle point... If CFR is 20% for an 80+ person in S. Korea that has symptoms & a positive test, what is the IFR for an  80+ person in the US who has a positive test but no symptoms (yet).   That number matters for judging the benefit/risk ratio of a treatment.

I haven't seen any studies that give the age-based incidence of asymptomatic cases.   The whole infection rate is so poorly understood right now.  (As I've said before, the Stanford antibody study may actually show in fact that there is very little community infection, suggesting relatively few asymptomatic cases.  But the maternity studies suggest high infection rates in those locales)

We may actually get numbers for some of the risk groups if areas are doing full (& repeated) testing in retirement homes.  Such numbers don't help with judging herd immunity, but they do help for treatment decisions for those at-risk individuals.